RGT 2.90% 35.5¢ argent biopharma limited

Ann: SwissPharmaCan AG increases initial purchase order, page-5

  1. 1,881 Posts.
    lightbulb Created with Sketch. 963
    “The Company has sufficient manufacturing capacity at its production facility in Slovenia to produce commercial scale batches of ArtemiCTM”
    >>>>>>>>>>>>>>>>>> “Commercial scale batches”?...Bullshit!

    The Slovenian plant is little more than a ‘pilot’ CBD extraction facility. It formed the bare bones to get GMP Certification that was promoted big time in the company marketing at the time. Now – not a word! I doubt this facility is even operational today!

    The Slovenian set-up is not a high production facility. It has a small CBD extraction plant with no product blending and packaging capabilities. Swiss PharmaCan
    will probably end up producing  ArtemiC themselves under license. This is the way they have operated with everything so far – farm out production to other facilities and hope for the best!


    How many announcements have we seen like this over the years? … PLENTY

    How many have actually materialised into a profit making concern for the company?...... NONE
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.